Delivery of Anti-miRNA-221 for Colorectal Carcinoma Therapy Using Modified Cord Blood Mesenchymal Stem Cells-Derived Exosomes
Siqi Han(China Agricultural University), Xiaoyuan Chu(Nanjing University of Chinese Medicine), Xiaoqin Ji(Nanjing General Hospital of Nanjing Military Command), Yulu Zhao(Nanjing General Hospital of Nanjing Military Command), Mengxi Huang(Nanjing General Hospital of Nanjing Military Command), Jiahe Yang(Southern Medical University), Cheng Chen(Nanchang University), Meng Jia(The University of Queensland), Chenglong He(Southern Medical University), Meijuan Wu(Nanjing General Hospital of Nanjing Military Command), Longwei Jiang(Southern Medical University), Guangchao Li(Shenyang Aerospace University)
Cited by 48
Related Papers
RETRACTED ARTICLE: MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial–mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma
|Molecular Cancer|2016|151
The Roles of MicroRNA-141 in Human Cancers: From Diagnosis to Treatment
|Cellular Physiology and Biochemistry|2016|115
Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential
|Cellular Physiology and Biochemistry|2015|80
Health service utilisation of rural‐to‐urban migrants in Guangzhou, China: does employment status matter?
|Tropical Medicine & International Health|2016|80